SCG’s HBV T-cell therapy shows promise in Phase I trial
SCG has revealed late-breaking data outcomes from the Phase I clinical trial of autologous hepatitis B virus (HBV)-specific T ...
Taiwan News12 小时
SCG Cell Therapy Presents Promising Phase 1 Data for a Novel HBV-Specific TCR-T Therapy ...
SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company focused on developing innovative immunotherapies for infectious diseases and associated cancers, announced late-breaking data ...
technologynetworks11 小时
Unveiling the Progress and Challenges in the Fight Against HIV
This article explores the difficulties faced in attempting to treat HIV, an innovative prevention strategy and the ...
Armed robbery in Revesby4 小时
Is Treatment For Genetic Autism On Horizon?
Prof. Boaz Barak A groundbreaking study from Tel Aviv University expands the understanding of the biological mechanism ...